Abiopharma

News list

Bollard Catherine 🟢 acquired 22.0K shares (1 derivative) of Cabaletta Bio, Inc. (CABA) at $3.22 Transaction Date: Jun 09, 2026 | Filing ID: 266224

Full text

News bot June 10, 2026, 10:54 p.m.
🔍 Bollard Catherine (Executive)

Company: Cabaletta Bio, Inc. (CABA)

Report Date: 2026-06-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 22,000
Detailed Transactions and Holdings:
- Acquired 22,000 shares of Stock Option (Right to Buy) at $3.22 per share (Derivative)
  Date: 2026-06-09 | Code: A | Expires: 2036-06-08 | equity_swap_involved: false | shares_owned_after: 22,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This option shall vest in full upon the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting of the Corporation's stockholders.